Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases: A Meta-analysis.

@article{Kwakman2016ClinicopathologicalPI,
  title={Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases: A Meta-analysis.},
  author={Riom Kwakman and Anne M Schrama and Josefien P van Olmen and Rene H J Otten and Elly S. M. de Lange-de Klerk and Erienne M.V. de Cuba and Geert Kazemier and Elisabeth Atie te Velde},
  journal={Annals of surgery},
  year={2016},
  volume={263 6},
  pages={1102-11}
}
OBJECTIVE To improve patient selection for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) by evaluating various preoperatively assessable clinicopathological parameters as markers for survival after CRS and HIPEC. SUMMARY BACKGROUND DATA Peritoneal metastases (PMs) originating from colorectal cancer are treated with CRS and HIPEC. Despite increasing survival, high morbidity and mortality warrant selection of patients with optimal benefit from this treatment… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 69 references

Predictors of progression in highgrade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

  • JM Baumgartner, L Tobin, SF Heavey
  • Ann Surg Oncol
  • 2015
2 Excerpts

Similar Papers

Loading similar papers…